TR199902725T2 - Flurbiprofen pastillerini yapmak i�in proses. - Google Patents

Flurbiprofen pastillerini yapmak i�in proses.

Info

Publication number
TR199902725T2
TR199902725T2 TR1999/02725T TR9902725T TR199902725T2 TR 199902725 T2 TR199902725 T2 TR 199902725T2 TR 1999/02725 T TR1999/02725 T TR 1999/02725T TR 9902725 T TR9902725 T TR 9902725T TR 199902725 T2 TR199902725 T2 TR 199902725T2
Authority
TR
Turkey
Prior art keywords
lozenge
lozenges
flurbiprofen
making
binder agent
Prior art date
Application number
TR1999/02725T
Other languages
English (en)
Turkish (tr)
Inventor
Day Andrew
Lyn Jones Huw
Simon Smith Carl
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of TR199902725T2 publication Critical patent/TR199902725T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/02725T 1997-05-22 1998-05-20 Flurbiprofen pastillerini yapmak i�in proses. TR199902725T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process

Publications (1)

Publication Number Publication Date
TR199902725T2 true TR199902725T2 (xx) 2000-02-21

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02725T TR199902725T2 (xx) 1997-05-22 1998-05-20 Flurbiprofen pastillerini yapmak i�in proses.

Country Status (31)

Country Link
US (1) US6194003B1 (h)
EP (1) EP0983059B1 (h)
JP (1) JP2001527567A (h)
KR (1) KR20010012739A (h)
CN (1) CN1154480C (h)
AR (1) AR015812A1 (h)
AT (1) ATE245021T1 (h)
AU (1) AU725760B2 (h)
BG (1) BG103881A (h)
BR (1) BR9809651A (h)
CA (1) CA2290830C (h)
CZ (1) CZ290816B6 (h)
DE (1) DE69816440T2 (h)
DK (1) DK0983059T3 (h)
ES (1) ES2202871T3 (h)
GB (1) GB9710521D0 (h)
HU (1) HU224954B1 (h)
ID (1) ID22949A (h)
IL (1) IL132999A0 (h)
IN (1) IN187837B (h)
MY (1) MY118410A (h)
NO (1) NO995681D0 (h)
NZ (1) NZ500664A (h)
PL (1) PL190947B1 (h)
PT (1) PT983059E (h)
RU (1) RU2203046C2 (h)
SK (1) SK283701B6 (h)
TR (1) TR199902725T2 (h)
UA (1) UA53714C2 (h)
WO (1) WO1998052539A1 (h)
ZA (1) ZA984260B (h)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124124B2 (en) 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2644400C (en) 2005-02-03 2014-04-08 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
CN103622926A (zh) * 2005-11-02 2014-03-12 帝国制药美国公司 感官上可接受的布洛芬口服给药制剂、制备和使用它的方法
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
KR20100020449A (ko) * 2007-07-23 2010-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 기호적으로 허용될 수 있는 인돌 세로토닌 수용체 작용제 경구 투여 제제 및 이를 사용하는 방법
WO2010020772A2 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
CA2860373C (en) 2011-04-29 2017-08-15 Moberg Pharma Ab Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
CN1255848A (zh) 2000-06-07
GB9710521D0 (en) 1997-07-16
RU2203046C2 (ru) 2003-04-27
EP0983059B1 (en) 2003-07-16
BR9809651A (pt) 2000-07-11
IN187837B (h) 2002-06-29
NO995681L (no) 1999-11-19
PL190947B1 (pl) 2006-02-28
SK283701B6 (sk) 2003-12-02
US6194003B1 (en) 2001-02-27
NO995681D0 (no) 1999-11-19
CZ412099A3 (cs) 2000-02-16
KR20010012739A (ko) 2001-02-26
AU725760B2 (en) 2000-10-19
BG103881A (bg) 2000-05-31
NZ500664A (en) 2001-01-26
CA2290830C (en) 2006-07-11
ATE245021T1 (de) 2003-08-15
AR015812A1 (es) 2001-05-30
EP0983059A1 (en) 2000-03-08
WO1998052539A1 (en) 1998-11-26
PT983059E (pt) 2003-11-28
PL336624A1 (en) 2000-07-03
HUP0002121A2 (hu) 2000-12-28
JP2001527567A (ja) 2001-12-25
ZA984260B (en) 1999-02-20
ID22949A (id) 1999-12-16
DK0983059T3 (da) 2003-11-03
DE69816440D1 (de) 2003-08-21
DE69816440T2 (de) 2004-05-13
SK158899A3 (en) 2000-05-16
HU224954B1 (en) 2006-04-28
CN1154480C (zh) 2004-06-23
AU7916598A (en) 1998-12-11
IL132999A0 (en) 2001-03-19
HUP0002121A3 (en) 2001-04-28
CA2290830A1 (en) 1998-11-26
UA53714C2 (uk) 2003-02-17
ES2202871T3 (es) 2004-04-01
MY118410A (en) 2004-10-30
CZ290816B6 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
TR199902725T2 (xx) Flurbiprofen pastillerini yapmak i�in proses.
IL89835A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
UA42023C2 (uk) Фармацевтична композиція, що містить гомогенну суміш модафінілових часток
ES2104797T3 (es) Composiciones farmaceuticas con actividad antagonista de angiotensina-ii.
ES2175940T3 (es) Formulacion farmaceutica de un compuesto didemnina.
BR9714072A (pt) Composições de esmaltes, processo para sua preparação e seu uso
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
AU568857B2 (en) Polymerisable composition containing inorganic material
AU7095687A (en) Pellet-containing pharmaceutical compositions
IT8323396A0 (it) Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed
IL93317A0 (en) Cell antiproliferation factor containing suppressin,processes for the preparation thereof and pharmaceutical compositions containing the same
DK0619113T3 (da) Til affarvning af hår anvendelig granulær peroxidsammensætning og fremgangsmåde til fremstilling deraf
ZA955788B (en) Dioxo-thiopyrano-pyridine-carboxylic acid derivatives
DK0815161T3 (da) Hidtil ukendte additivkoncentrater
BR9812152A (pt) Comprimidos de cloramina t prensados e processos para a sua preparação
DE69717045D1 (de) Aminocarbamate von Polyalkylphenoxyalkanolen, und die selben enthaltende Brennstoffzusammensetzungen
IT8424266A0 (it) Composizioni farmaceutiche e loro uso come midriatici.
NO176462C (no) Granulert mineralblanding og fremgangsmåte til fremstilling derav
RU97120470A (ru) Вещества взрывчатые промышленные типа "комбизар"
ES549983A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas
BR9714559A (pt) Composição refratária fundìvel e métodos de fabricação de corpos refratários
KR910013462U (ko) 방송방식의 혼용사용이 가능한 피아이피 시스템
AU573123C (en) Amlodipine benzene sulphonate and pharmaceutical compositions thereof
AU573123B2 (en) Amlodipine benzene sulphonate and pharmaceutical compositions thereof
IL87997A0 (en) Oxindole anti-inflammatory agents and pharmaceutical compositions comprising them